Collaboration the only viable way to protect the pharma supply chain, warns GSK
Pharmaceutical manufacturers and their supply chain partners need to improve their business continuity planning to deal with threats from terrorist attacks, political instability and unforeseen climate events, according to Stephen Mitchell, quality assurance and compliance manager at GlaxoSmithKline.
Dr Mitchell warned the Air Cargo News Life Sciences & Pharmaceuticals Conference in London of the potential catastrophic impact of so-called “black swan” incidents.
While human error can never be eliminated – there have been cases where entire vaccine shipments froze when fahrenheit temperatures were misread as centigrade – he charted a number of ways of reducing risk.
Source: The Loadstar
